As of May 27
| +0.13 / +0.30%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 46.85, with a high estimate of 60.47 and a low estimate of 36.62. The median estimate represents a +7.67% increase from the last price of 43.51.
The current consensus among 31 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.